Assessment of an Internet Blood Glucose Management Program in a Chronic Care Hospital
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- HbA1c
研究概览
简要总结
The incidence of type 2 diabetes in long term care facilities has been approximated at 25% with barriers to treatment including untimely access to a specialist and improper/poor adherence to insulin regimes. This 3 month trial will investigate the efficacy of improving overall glycemic control by using an internet blood glucose reporting system to facilitate bi-weekly consultations between long term care facility patients with type 2 diabetes and an endocrinologist.
详细描述
Purpose: This project will investigate the benefits (as measured by change in the primary outcome measure hemoglobin A1c) of bi-weekly reporting of blood sugar values for patients with type 2 diabetes in long term care facilities.
Hypothesis: Our hypothesis is bi-weekly reporting will result in a reduction in A1c after 3 months.
Justification: Elevated A1c values increase risk of health complications for people with type 2 diabetes.
Objectives: Improved type 2 diabetes management for patients in long term care facilities.
Research Methods: Patients who meet the inclusion / exclusion criteria and are interested in participating in the study will self-identify to the research coordinator. Consent will be done in person with any questions answered. Strips and blood glucose meters will be provided. Blood glucose values and testing frequency will be recorded using the internet reporting system Heath-e-Connect. HbA1c, serum creatinine and demographic data will be collected at 0 and 3 months to determine effect of bi-weekly remote communication of blood glucose with an endocrinologist.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type II diabetes mellitus patients at Point Grey Private Hospital
- •Trained in self-blood glucose monitoring
- •Willingness to test blood glucose levels a minimum of 3 times daily
- •Willingness to be trained on IBGMS
排除标准
- •Patients with medical conditions that may affect their study participation or results will be excluded.
- •Patients currently being treated with steroid medication
- •Patients that have impaired liver function
结局指标
主要结局
HbA1c
时间窗: 0 and 3 months
Hemoglobin A1c will be measure at 0 and 3 months to determine the efficacy of the internet blood glucose monitoring system as measured by change in glycemic control.
次要结局
- Frequency of Self-Monitoring(3 months)
- Staff satisfaction(3 months)
- unplanned hospitalizations(3 months)
研究者
Dr. Hugh Tildesley
Director
Endocrine Research Society